RetinalGenix Technologies (RTGN) Total Current Liabilities (2023 - 2026)
RetinalGenix Technologies (RTGN) posted Total Current Liabilities of $2.6 million for Q1 2026, up 10.38% sequentially from $2.3 million in Q4 2025, and up 53.02% YoY from $1.7 million in Q1 2025.
RetinalGenix Technologies (RTGN) Total Current Liabilities (2023 - 2026) Analysis & Trends
RetinalGenix Technologies has reported Total Current Liabilities for 4 years, with the latest figure at $2.6 million in Q1 2026.
- Quarterly Total Current Liabilities rose 53.02% year-over-year to $2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (up 53.02% YoY) and the FY2025 annual result came in at $2.3 million, up 57.71% from the prior year.
- Total Current Liabilities improved to $2.6 million in Q1 2026 per RTGN's latest filing, from $2.3 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $2.6 million in Q1 2026 and troughed at $1.4 million in Q4 2023.
- A 4-year average of $1.9 million and a median of $2.0 million in 2024 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities advanced 4.64% in 2024, then soared 57.71% in 2025.
- Over 4 years, Total Current Liabilities stood at $1.4 million in 2023, then gained by 4.64% to $1.5 million in 2024, then jumped by 57.71% to $2.3 million in 2025, then gained by 10.38% to $2.6 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $2.6 million, $2.3 million, and $2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.20 Bn | 193.60 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 127.66 Bn | 124.19 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.37 Bn | 32.42 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.89 Bn | 31.78 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 1.28 Bn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | 2.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.56 Mn |
| Dec 31, 2025 | 2.32 Mn |
| Sep 30, 2025 | 2.17 Mn |
| Jun 30, 2025 | 1.98 Mn |
| Mar 31, 2025 | 1.67 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Sep 30, 2024 | 1.94 Mn |
| Dec 31, 2023 | 1.41 Mn |